Dagny Luong
Ophthalmology · Hemet, CANPI 1790044626
Payments from drug & device makers
Across 746 payments — averaging $2199.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$1.2M
- Alcon$281K
- AbbVie$54K
- Bausch & Lomb Americas Inc.$48K
- Johnson & Johnson Surgical Vision, Inc.$11K
- Lensar, Inc.$8K
- plus $24K from 19 others
Across 10 payments — averaging $27,269 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$271K
- Oyster Point Pharma, Inc.$2K
What the payments were for
- Consulting fees$367,98972%
- Speaking & faculty fees$90,63318%
- Travel & lodging$28,6606%
- Food & beverage$20,4374%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 70 | $1,215,422 |
| Alcon | 268 | $280,543 |
| AbbVie(2 entities) | 97 | $53,815 |
| Bausch & Lomb Americas Inc. | 86 | $48,175 |
| Johnson & Johnson Surgical Vision, Inc. | 52 | $11,094 |
| Lensar, Inc. | 6 | $8,234 |
| Tarsus Pharmaceuticals, Inc. | 21 | $4,976 |
| Eyevance Pharmaceuticals LLC | 16 | $4,456 |
| Tearlab Corp | 7 | $3,014 |
| Glaukos Corporation | 8 | $2,836 |
| Oyster Point Pharma, Inc. | 29 | $2,146 |
| Harrow Eye, LLC | 17 | $2,014 |
| Kala Pharmaceuticals, Inc. | 7 | $1,501 |
| Beaver-visitec International, Inc. | 2 | $690 |
| Novartis | 22 | $459 |
| Carl Zeiss Meditec, Inc. | 5 | $420 |
| Sun Pharmaceutical Industries Inc. | 12 | $339 |
| Rxsight Inc | 6 | $286 |
| Rayner Intraocular Lenses Limited | 7 | $232 |
| Carl Zeiss Meditec USA, Inc. | 1 | $80 |
| Ocular Therapeutix, Inc. | 1 | $61 |
| Sight Sciences, Inc. | 2 | $59 |
| Amgen | 1 | $45 |
| Shire North American Group Inc | 2 | $39 |
| Biotissue Holdings Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AcrySof IQ VIVITY$138,997
- AcrySof IQ PanOptix UV IOL$138,843
- Clareon$93,370
- VUITY$44,808
- MIEBO$34,877
- XIIDRA$33,810
- WaveLight EX500 Excimer Laser$33,053
- Wavelight$28,103
- Systane$14,000
- LenSx$14,000
- ILUX$14,000
- Centurion$12,600
- ARGOS$11,905
- Wavelight Refractive Suite$11,821
- AcrySof IQ VIVITY IOL$9,800
- Tecnis Simplicity$9,769
- LENSAR LASER SYSTEM$8,200
- Hydrus Microstent$7,000
- Unity$6,500
- NGENUITY$5,600
How this compares
$1,640,957 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 14 | $148 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Hemet
- Nisha AcharyaSan Francisco$33M
- David WirtaNewport Beach$18.4M
- Michael IpPasadena$10.2M
- Raymond DouglasBeverly Hills$9.7M
- Sherif El HaraziGlendale$9.2M
- Daniel SchwartzSan Francisco$8M
- Nikolas Londonla Jolla$6.1M
- Michael BerlinWest Hollywood$5.7M
- Steven JacobsonLos Angeles$4.7M
- Peter WinArcadia$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.